Related Experiment Video

Updated: May 25, 2026

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro
11:06

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro

Published on: January 31, 2022

Therapeutic potential of Liver Receptor Homolog-1 modulators

Kyren A Lazarus1, Dhilushi Wijayakumara, Ashwini L Chand

  • 1Prince Henry's Institute, Clayton, Victoria 3168, Australia.

The Journal of Steroid Biochemistry and Molecular Biology
|January 24, 2012
PubMed

Insights

Liver Receptor Homolog-1 (LRH-1) is crucial for development and homeostasis. New synthetic ligands offer potential therapies for diseases linked to LRH-1 dysfunction.

Area of Science:

  • Molecular biology
  • Endocrinology
  • Developmental biology

Background:

  • Liver Receptor Homolog-1 (LRH-1; NR5A2) is an orphan nuclear receptor.
  • LRH-1 is essential for early development, cholesterol homeostasis, and steroidogenesis.
  • Aberrant LRH-1 expression is implicated in various diseases, including cancer.

Purpose of the Study:

  • To summarize the known functions and regulatory mechanisms of LRH-1.
  • To highlight recent advancements in identifying synthetic ligands for LRH-1.
  • To explore the therapeutic potential of these ligands.

Main Methods:

  • Literature review of studies on LRH-1.
  • Analysis of LRH-1's role in different biological processes.
  • Review of recent findings on synthetic LRH-1 ligands.

Main Results:

  • LRH-1 is expressed in key tissues like embryonic stem cells, liver, intestine, pancreas, and ovary.
  • It functions as a monomer and is regulated by ligand-dependent and -independent pathways.
  • Synthetic ligands targeting LRH-1 have been identified.

Conclusions:

  • LRH-1 plays critical roles in multiple physiological processes.
  • Targeting LRH-1 with synthetic ligands presents a promising therapeutic strategy.
  • Further research into LRH-1 modulation could address various pathological conditions.

Related Concept Videos

Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.
The Two-State Receptor Model01:29

The Two-State Receptor Model

The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with one...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...